4//SEC Filing
GILBERTSON RYAN RANDALL 4
Accession 0001437749-19-001249
CIK 0001029125other
Filed
Jan 23, 7:00 PM ET
Accepted
Jan 24, 11:59 AM ET
Size
10.8 KB
Accession
0001437749-19-001249
Insider Transaction Report
Form 4
GILBERTSON RYAN RANDALL
10% Owner
Transactions
- Sale
Warrants (right to buy)
2018-08-15−47,025→ 0 total(indirect: Northern Capital Partners I, LP)Exercise: $5.00From: 2018-05-16Exp: 2021-05-16→ Common Stock (47,025 underlying) - Sale
Common Stock
2018-08-15−47,025→ 0 total(indirect: Northern Capital Partners I, LP)
Holdings
- 555,538
Common Stock
Footnotes (1)
- [F1]47,025 units, with each unit consisting of one share of common stock and a warrant to purchase an additional share of common stock, were sold by the reporting person for an aggregate price of $200,000.
Issuer
Sun BioPharma, Inc.
CIK 0001029125
Entity typeother
Related Parties
1- filerCIK 0001394821
Filing Metadata
- Form type
- 4
- Filed
- Jan 23, 7:00 PM ET
- Accepted
- Jan 24, 11:59 AM ET
- Size
- 10.8 KB